Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Disulfiram in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating disulfiram for rheumatoid arthritis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disulfiram (Disulfiram)

Snippet

Sponsor: University of Oklahoma | Conditions: Rheumatoid Arthritis, Inflammation | Phase 2 | Status: NOT_YET_RECRUITING